![Global Uveitis Treatment Market](https://res.cloudinary.com/devmoveo/image/upload/v1690906501/skyquest/report/phpVXmLF5.jpg)
Report ID: SQMIG35A2404
Report ID:
SQMIG35A2404 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
92 |
Figures:
76
Uveitis Treatment Market size was valued at USD 0.7 billion in 2022 and is poised to grow from USD 0.75 billion in 2023 to USD 1.18 billion by 2030, at a CAGR of 6.7% during the forecast period (2023-2030).
The field of ophthalmology is experiencing a notable surge in research and development activities, which is contributing to the rapid growth of the market.
Globally, there is an increasing number of clinical trials focused on treating eye inflammation, particularly for refractory posterior or intermediate uveitis. Several phase III trials are underway to evaluate the efficacy of new treatments, such as mycophenolate mofetil and methotrexate, as standard corticosteroid therapies for noninfectious uveitis cases.
Additionally, the development of biological drugs through extensive R&D efforts has significantly improved the treatment options for eye inflammation disorders. This, in turn, is driving the demand for such drugs and fueling market growth.
US Uveitis Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2404